| Titre : | Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California (2025) |
| Auteurs : | Nicola Manalili, Auteur ; Jenelle Merzon, Auteur ; Julia Alber, Auteur ; Adrienne Lent, Auteur |
| Type de document : | Article : texte imprimé |
| Dans : | American Journal of Health Promotion (vol. 39, n° 5, juin 2025) |
| Article en page(s) : | pp. 813–818 |
| Langues : | Anglais |
| Catégories : | |
| Résumé : |
"Purpose
To examine associations between identified factors to accessing Food and Drug Administration-approved quit medication (FDAQM) and use among a sample of tobacco users. Design Cross-sectional, online survey. Setting County in Central California. Subjects Current adult tobacco users (n = 76). Measures Demographics self-reported likelihood of quitting in the next month, contacting a healthcare provider about quitting, time since last healthcare visit, provider asking about tobacco/nicotine use, provider advice to quit, provider FDAQM prescription and FDAQM use in the past year. Analysis Logistic regression. Results Those with a higher likelihood of quitting had a lower odds of FDAQM use (OR = 0.15, 95% CI = 0.03, 0.73) while those who had contacted a healthcare provider had a higher odds (OR = 15.39, 95% CI = 2.72, 87.05). Conclusion While the sample was limited, this research provides evidence in an understudied tobacco cessation area. More work is needed to understand the generalizability of these results and develop interventions that address these factors." |
| Catalogueur : | RESOdoc |
Exemplaires (1)
| Cote | Code-barres | Support | Localisation | Disponibilité |
|---|---|---|---|---|
| RESO A.19 | RE65682749 | Bulletin | RESOdoc | Consultation sur place Disponible |
